Tumor-promoting immune cells, including dendritic cells (DCs), macrophages, and monocytes, may promote tumor growth, metastasis, and drug resistance in the TME, whereas antitumor immune cells, namely B cells, natural killer (NK) cells, and CD8+ T cells, suppress tumor cell proliferation, invasion, adhesion, and metastasis. This evidence concerns the gene CD8A and neoplasm.